#2319 - Rick Doblin

#2319 - Rick Doblin

Up next

#2513 - Dean Radin

Dean Radin, PhD, is Chief Scientist at the Institute of Noetic Sciences (IONS), Associate Distinguished Professor at the California Institute of Integral Studies, and co-founder and chairman of the neuroengineering company Cognigenics. His latest book is “The Science of Magic: Ho ...  Show more

#2512 - Joey Diaz

Joey Diaz is a stand-up comedian, actor, and writer. He is the host of the podcast “The Church of What’s Happening Now: The New Testament” and the author of “Tremendous: The Life of a Comedy Savage.”www.youtube.com/@JoeyDiazwww.patreon.com/JoeyDiazwww.joeydiaz.net Perplexity: Dow ...  Show more

Recommended Episodes

Rick Doblin
Flow Sessions with Jason Silva

Rick Doblin is the founder and executive director of the Multi-Disciplinary Association for Psychedelic Studies, MAPS. He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of ...  Show more

#280 - Psychonaut Scientist Reveals The ANCIENT Beings Hiding in DMT Hyperspace | Dennis McKenna | Dennis Mckenna
Danny Jones Podcast

Sign up for the Coca Summit in Peru - https://bit.ly/40uRj6s Dennis McKenna is an ethnopharmacologist, author, and brother to well-known psychedelics proponent Terence McKenna. Dennis currently runs the @mckenna.academy YouTube channel. SPONSORS https://hims.com/danny - Start you ...  Show more

Promising new results from psychedelic clinical trials
Psychedelic Therapy Frontiers

Send us Fan MailThe path to FDA approved prescribable medicine has been a long and precarious one for psychedelics. However, recent reports by some of the major players in the psychedelic medicine space show promising results from clinical trials involving psilocybin and 5-MeO-DM ...  Show more

Ecstasy Therapy: Penicillin for the soul
Today, Explained

In 1980s Berkeley, an eccentric chemist and his wife, a self-taught therapist, experimented with MDMA. Their work would kickstart a decades-long campaign to mainstream psychedelics as a therapeutic tool — one that’s coming to a head this month, with a decision due from the FDA. T ...  Show more